{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:40:52Z","timestamp":1792730452515,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,5,6]],"date-time":"2012-05-06T00:00:00Z","timestamp":1336262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00246-012-0322-8","type":"journal-article","created":{"date-parts":[[2012,5,5]],"date-time":"2012-05-05T18:32:36Z","timestamp":1336242756000},"page":"1332-1342","source":"Crossref","is-referenced-by-count":7,"title":["Intrapulmonary Shear Stress Enhancement: A New Therapeutic Approach in Pulmonary Arterial Hypertension"],"prefix":"10.1007","volume":"33","author":[{"given":"Sayed","family":"Nour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Carbognani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minze","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daya","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermine","family":"Lila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Chachques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,6]]},"reference":[{"issue":"Suppl 5 Pt 2","key":"322_CR1","first-page":"591","volume":"58","author":"CM Schannwell","year":"2007","unstructured":"Schannwell CM, Steiner S, Strauer BE (2007) Diagnostics in pulmonary hypertension. J Physiol Pharmacol 58(Suppl 5 Pt 2):591\u2013602","journal-title":"J Physiol Pharmacol"},{"key":"322_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jacc.2009.04.012","volume":"54","author":"G Simonneau","year":"2009","unstructured":"Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP et al (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54:43\u201354","journal-title":"J Am Coll Cardiol"},{"key":"322_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jacc.2004.02.029","volume":"43","author":"M Humbert","year":"2004","unstructured":"Humbert M, Morrell NW, Archer SL (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43:13\u201324","journal-title":"J Am Coll Cardiol"},{"key":"322_CR4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","volume":"342","author":"GM Felker","year":"2000","unstructured":"Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL et al (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:1077\u20131084","journal-title":"N Engl J Med"},{"key":"322_CR5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1753465808094762","volume":"2","author":"K Boutet","year":"2008","unstructured":"Boutet K, Montani D, Ja\u00efs X (2008) Review: therapeutic advances in pulmonary arterial hypertension. Ther Adv Respir Dis 2:249\u2013265","journal-title":"Ther Adv Respir Dis"},{"key":"322_CR6","doi-asserted-by":"crossref","unstructured":"Checchia PA, Bronicki RA, Goldstein B (2012) Review of inhaled nitric oxide in the pediatric cardiac surgery setting. Pediatr Card [Epub Ahead of Print]","DOI":"10.1007\/s00246-012-0172-4"},{"key":"322_CR7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/PCC.0b013e31816c7035","volume":"9","author":"RB Tessler","year":"2008","unstructured":"Tessler RB, Zadinello M, Fiori H, Colvero M, Belik J, Fiori RM (2008) Tadalafil improves oxygenation in a model of newborn pulmonary hypertension. Pediatr Crit Care Med 9:330\u2013332","journal-title":"Pediatr Crit Care Med"},{"key":"322_CR8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejcts.2010.01.045","volume":"38","author":"S Nemoto","year":"2010","unstructured":"Nemoto S, Sasaki T, Ozawa H, Katsumata T, Okumura K et al (2010) Oral sildenafil for persistent pulmonary hypertension early after congenital cardiac surgery in children. Eur J Cardiothorac Surg 38:71\u201377","journal-title":"Eur J Cardiothorac Surg"},{"key":"322_CR9","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","volume":"55","author":"VV McLaughlin","year":"2010","unstructured":"McLaughlin VV, Benza RL, Rubin LJ, Channick RN, Voswinckel R, Tapson VF et al (2010) Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. J Am Coll Cardiol 55:1915\u20131922","journal-title":"J Am Coll Cardiol"},{"key":"322_CR10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/hrt.2008.156299","volume":"96","author":"HM Nef","year":"2010","unstructured":"Nef HM, M\u00f6llmann H, Hamm C (2010) Pulmonary hypertension: updated classification and management of pulmonary hypertension. Heart 96:552\u2013559","journal-title":"Heart"},{"key":"322_CR11","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ahj.2007.02.037","volume":"153","author":"A Macchia","year":"2007","unstructured":"Macchia A, Marchioli R, Marfisi R (2007) A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology. Am Heart J 153:1037\u20131047","journal-title":"Am Heart J"},{"key":"322_CR12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1164\/rccm.2601002","volume":"173","author":"A Bush","year":"2006","unstructured":"Bush A (2006) Pulmonary and critical care updates (update in pediatrics 2005). Am J Respir Crit Care Med 173:585\u2013592","journal-title":"Am J Respir Crit Care Med"},{"key":"322_CR13","doi-asserted-by":"crossref","first-page":"L359","DOI":"10.1152\/ajplung.00019.2005","volume":"290","author":"P Oishi","year":"2006","unstructured":"Oishi P, Grobe A, Benavidez E (2006) Inhaled nitric oxide induced NOS inhibition and rebound pulmonary hypertension: a role for superoxide and peroxynitrite in the intact lamb. Am J Physiol Lung Cell Mol Physiol 290:L359\u2013L366","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"322_CR14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(95)92681-X","volume":"346","author":"OI Miller","year":"1995","unstructured":"Miller OI, Tang SF, Keech A, Celermajer DS (1995) Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide [letter]. Lancet 346:51\u201352","journal-title":"Lancet"},{"key":"322_CR15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2165\/00002018-200528110-00001","volume":"28","author":"ES Segal","year":"2005","unstructured":"Segal ES, Valette C, Oster L (2005) Risk management strategies in the postmarketing period: safety experience with the US and European Bosentan Surveillance Programmes. Drug Saf 28:971\u2013980","journal-title":"Drug Saf"},{"key":"322_CR16","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1513\/pats.200803-027HR","volume":"5","author":"T Stevens","year":"2008","unstructured":"Stevens T (2008) Lung vascular cell heterogeneity: endothelium, smooth muscle, and fibroblasts. Proc Am Thorac Soc 5:783\u2013791","journal-title":"Proc Am Thorac Soc"},{"key":"322_CR17","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1161\/01.CIR.0000074210.49434.40","volume":"107","author":"S Khambadkone","year":"2003","unstructured":"Khambadkone S, Li J, de Leval MR, Cullen S, Deanfield JE, Redington AN (2003) Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation. Circulation 107:3204\u20133208","journal-title":"Circulation"},{"key":"322_CR18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1183\/09059180.00007109","volume":"19","author":"ML Handoko","year":"2010","unstructured":"Handoko ML, de Man FS, Allaart CP, Paulus WJ, Westerhof N, Vonk-Noordegraaf A (2010) Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart. Eur Respir Rev 19:72\u201382","journal-title":"Eur Respir Rev"},{"key":"322_CR19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1164\/rccm.201003-0469OC","volume":"183","author":"CP Aaron","year":"2011","unstructured":"Aaron CP, Tandri H, Barr RG, Johnson WC, Bagiella E, Chahal H (2011) Physical activity and right ventricular structure and function. The MESA Right Ventricle Study. Am J Respir Crit Care Med 183:396\u2013404","journal-title":"Am J Respir Crit Care Med"},{"key":"322_CR20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3934\/mbe.2004.1.61","volume":"1","author":"MS Olufsen","year":"2004","unstructured":"Olufsen MS, Nadim A (2004) On deriving lumped models for blood flow and pressure in the systemic arteries. Math Biosci Eng 1:61\u201380","journal-title":"Math Biosci Eng"},{"key":"322_CR21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1109\/MEMB.2003.1237504","volume":"22","author":"RJ Roselli","year":"2003","unstructured":"Roselli RJ, Brophy SP (2003) Redesigning a biomechanics course using challenge-based instruction. IEEE Eng Med Biol Mag 22:66\u201370","journal-title":"IEEE Eng Med Biol Mag"},{"key":"322_CR22","first-page":"45","volume":"58","author":"G Gonzales-Luis","year":"2007","unstructured":"Gonzales-Luis G, Fletcher AJ, Moreno L (2007) Nitric oxide-mediated nonadrenergic noncholinergic relaxation of piglet pulmonary arteries decreases with postnatal age. J Physiol Pharmacol 58:45\u201356","journal-title":"J Physiol Pharmacol"},{"key":"322_CR23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","volume":"288","author":"RF Furchgott","year":"1980","unstructured":"Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373\u2013376","journal-title":"Nature"},{"key":"322_CR24","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0140-6736(89)91013-1","volume":"2","author":"P Vallance","year":"1989","unstructured":"Vallance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2:997\u20131000","journal-title":"Lancet"},{"key":"322_CR25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cardiores.2007.04.014","volume":"75","author":"KD Bloch","year":"2007","unstructured":"Bloch KD, Ichinose F, Roberts JD Jr, Zapol WM (2007) Inhaled NO as a therapeutic agent. Cardiovasc Res 75:339\u2013348","journal-title":"Cardiovasc Res"},{"key":"322_CR26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1358\/dot.2011.47.2.1544337","volume":"47","author":"YD Levin","year":"2011","unstructured":"Levin YD, White RJ (2011) Novel therapeutic approaches in pulmonary arterial hypertension: focus on tadalafil. Drugs Today (Barc) 47:145\u2013156","journal-title":"Drugs Today (Barc)"},{"key":"322_CR27","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1590\/S0066-782X2006001800027","volume":"87","author":"AC Carvalho de","year":"2006","unstructured":"de Carvalho AC, Hovnanian AL, Fernandes CJ, Lapa M, Jardim C, Souza R (2006) Tadalafil as treatment for idiopathic pulmonary arterial hypertension. Arq Bras Cardiol 87:e195\u2013e197","journal-title":"Arq Bras Cardiol"},{"key":"322_CR28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1073\/pnas.98.1.355","volume":"98","author":"DD Thomas","year":"2001","unstructured":"Thomas DD, Liu X, Kantrow SP (2001) The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. Proc Natl Acad Sci USA 98:355\u2013360","journal-title":"Proc Natl Acad Sci USA"},{"key":"322_CR29","first-page":"39","volume":"11","author":"GG Neri Serneri","year":"1981","unstructured":"Neri Serneri GG (1981) Pathophysiological aspects of platelet aggregation in relation to blood flow rheology in microcirculation. Ric Clin Lab 11:39\u201346","journal-title":"Ric Clin Lab"},{"key":"322_CR30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/0218492309348638","volume":"17","author":"S Nour","year":"2009","unstructured":"Nour S, Wu G, Zhensheng Z, Chachques JC, Carpentier A, Payen D (2009) The forgotten driving forces in right heart failure: new concept and device. Asian Cardiovasc Thorac Ann 17:525\u2013530","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"322_CR31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/cvr\/26.9.839","volume":"26","author":"PR Fourie","year":"1992","unstructured":"Fourie PR, Coetzee AR, Bolliger CT (1992) Pulmonary artery compliance: its role in right ventricular-arterial coupling. Cardiovasc Res 26:839\u2013844","journal-title":"Cardiovasc Res"},{"key":"322_CR32","first-page":"1446","volume":"89","author":"N Kitamura","year":"1988","unstructured":"Kitamura N, Miki T, Fukushima Y, Yamaguchi A, Otaki M, Minoji T (1988) Expanding the surgical indication to the cases with high risk valve diseases. Nihon Geka Gakkai Zasshi 89:1446\u20131449","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"322_CR33","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0003-4975(93)90286-Q","volume":"55","author":"GV Letsou","year":"1993","unstructured":"Letsou GV, Franco KL, Detmer W (1993) Pulmonary artery balloon counterpulsation: safe after peripheral placement. Ann Thorac Surg 55:741\u2013746","journal-title":"Ann Thorac Surg"},{"key":"322_CR34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0029-1233311","volume":"30","author":"M Beghetti","year":"2009","unstructured":"Beghetti M, Tissot C (2009) Pulmonary arterial hypertension in congenital heart diseases. Semin Respir Crit Care Med 30:421\u2013428","journal-title":"Semin Respir Crit Care Med"},{"key":"322_CR35","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2165\/00003495-200868080-00004","volume":"68","author":"N Galie","year":"2008","unstructured":"Galie N, Manes A, Palazzini M, Negro L, Marinelli A, Gambetti S (2008) Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger\u2019s syndrome. Drugs 68:1049\u20131066","journal-title":"Drugs"},{"key":"322_CR36","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.CIR.97.9.916","volume":"97","author":"JG Motwani","year":"1998","unstructured":"Motwani JG, Topol EJ (1998) Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97:916\u2013931","journal-title":"Circulation"},{"key":"322_CR37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2008.02.004","volume":"129","author":"K Dimopoulos","year":"2008","unstructured":"Dimopoulos K, Peset A, Gatzoulis MA (2008) Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy. Int J Cardiol 129:163\u2013171","journal-title":"Int J Cardiol"},{"key":"322_CR38","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/ejechocard\/jer127","volume":"12","author":"SA Pyxaras","year":"2011","unstructured":"Pyxaras SA, Pinamonti B, Barbati G, Santangelo S, Valentincic M, Cettolo F et al (2011) Echocardiographic evaluation of systolic and mean pulmonary artery pressure in the follow-up of patients with pulmonary hypertension. Eur J Echocardiogr 12:696\u2013701","journal-title":"Eur J Echocardiogr"},{"key":"322_CR39","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/CIRCULATIONAHA.108.808246","volume":"119","author":"DM Smadja","year":"2009","unstructured":"Smadja DM, Gaussem P, Mauge L, Isra\u00ebl-Biet D, Dignat-George F, Peyrard S et al (2009) Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease. Circulation 119:374\u2013381","journal-title":"Circulation"},{"key":"322_CR40","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0003-4975(99)00562-7","volume":"68","author":"C Mavroudis","year":"1999","unstructured":"Mavroudis C, Backer CL, Kohr LM, Deal BJ, Stinios J, Muster AJ et al (1999) Bidirectional Glenn shunt in association with congenital heart repairs: the 1(1\/2) ventricular repair. Ann Thorac Surg 68:976\u2013981","journal-title":"Ann Thorac Surg"},{"key":"322_CR41","doi-asserted-by":"crossref","unstructured":"Nour S (2012) Flow and rate: concept and clinical applications of a new hemodynamic theory. In: Misra AN (ed) Biophysics. Intech, Rijeka, pp 17\u201376","DOI":"10.5772\/32771"},{"key":"322_CR42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0030-1253452","volume":"36","author":"CD Ochoa","year":"2010","unstructured":"Ochoa CD, Wu S, Stevens T (2010) New developments in lung endothelial heterogeneity: Von Willebrand factor, P-selectin, and the Weibel-Palade body. Semin Thromb Hemost 36:301\u2013308","journal-title":"Semin Thromb Hemost"},{"key":"322_CR43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/BF03044431","volume":"24","author":"KH Scholz","year":"1999","unstructured":"Scholz KH (1999) Reperfusion therapy and mechanical circulatory support in patients in cardiogenic shock. Herz 24:448\u2013464","journal-title":"Herz"},{"key":"322_CR44","unstructured":"Nour S, Dai G, Wang Q, Wang F, Chachques JC, Wu GF (2012) The forgotten driving forces in right heart failure: Preclinical experimental study. Asian Cardiovasc Thorac Ann doi: 10.1177\/0123456789123456"},{"key":"322_CR45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.CCM.0000300545.90116.B9","volume":"36","author":"M Thomas","year":"2008","unstructured":"Thomas M (2008) Management of pulmonary hypertension in the intensive care unit. Crit Care Med 36:651\u2013652","journal-title":"Crit Care Med"},{"key":"322_CR46","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1097\/01.CCM.0000280433.74246.9E","volume":"35","author":"RT Zamanian","year":"2007","unstructured":"Zamanian RT, Haddad F, Doyle RL, Weinacker AB (2007) Management strategies for patients with pulmonary hypertension in the intensive care unit. Crit Care Med 35:2037\u20132050","journal-title":"Crit Care Med"},{"key":"322_CR47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1164\/rccm.2310015","volume":"169","author":"IM Robbins","year":"2004","unstructured":"Robbins IM (2004) Advancing therapy for pulmonary arterial hypertension: can animal models help? Am J Respir Crit Care Med 169:5\u20136","journal-title":"Am J Respir Crit Care Med"},{"key":"322_CR48","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1152\/ajplung.00281.2007","volume":"293","author":"NR Bauer","year":"2007","unstructured":"Bauer NR, Moore TM, McMurtry IF (2007) Rodent models of PAH: are we there yet? Am J Physiol Lung Cell Mol Physiol 293:580\u2013582","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"322_CR49","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1152\/ajpheart.01012.2006","volume":"292","author":"Z Ghorishi","year":"2007","unstructured":"Ghorishi Z, Milstein JM, Poulain FR, Moon-Grady A, Tacy T, Bennett SH et al (2007) Shear stress paradigm for perinatal fractal arterial network remodeling in lambs with pulmonary hypertension and increased pulmonary blood flow. Am J Physiol Heart Circ Physiol 292:3006\u20133018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"322_CR50","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1017\/S1047951101000543","volume":"11","author":"EV Stenb\u00f8g","year":"2001","unstructured":"Stenb\u00f8g EV, Steinbr\u00fcchel DA, Thomsen AB, Baandrup U, Heickendorff L et al (2001) The pulmonary vasculature in a neonatal porcine model with increased pulmonary blood flow and pressure. Cardiol Young 11:420\u2013430","journal-title":"Cardiol Young"},{"key":"322_CR51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4613-2305-1_1","volume-title":"The genetics of cardiovascular disease","author":"EB Clark","year":"1987","unstructured":"Clark EB (1987) Mechanisms in the pathogenesis of congenital cardiac malformations. In: Pierpont MEM, Moller JH (eds) The genetics of cardiovascular disease. Nijhoff Publishing, Boston, pp 3\u201311"},{"key":"322_CR52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PCC.0b013e3181c769a4","volume":"11","author":"MB Taylor","year":"2010","unstructured":"Taylor MB, Laussen PC (2010) Fundamentals of management of acute postoperative pulmonary hypertension. Pediatr Crit Med 11:27","journal-title":"Pediatr Crit Med"},{"key":"322_CR53","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ejcts.2004.01.052","volume":"25","author":"J Martin","year":"2004","unstructured":"Martin J, Siegenthaler MP, Friesewinkel O (2004) Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation\u2014a preliminary study. Eur J Cardiothorac Surg 25:971\u2013977","journal-title":"Eur J Cardiothorac Surg"},{"key":"322_CR54","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cardfail.2011.02.008","volume":"17","author":"I Wilmot","year":"2011","unstructured":"Wilmot I, Morales DL, Price JF (2011) Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis. J Card Fail 17:487\u2013494","journal-title":"J Card Fail"},{"key":"322_CR55","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ccd.20995","volume":"69","author":"J Pihkala","year":"2007","unstructured":"Pihkala J, Yazaki S, Mehta R, Lee KJ, Chaturvedi R, McCrindle BW et al (2007) Feasibility and clinical impact of transcatheter closure of interatrial communications after a fenestrated Fontan procedure: medium-term outcomes. Catheter Cardiovasc Interv 69:1007\u20131014","journal-title":"Catheter Cardiovasc Interv"},{"key":"322_CR56","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1517\/14656566.2.5.845","volume":"2","author":"B Falase","year":"2001","unstructured":"Falase B, Easaw J, Youhana A (2001) The role of nicorandil in the treatment of myocardial ischaemia. Expert Opin Pharmacother 2:845\u2013856","journal-title":"Expert Opin Pharmacother"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-012-0322-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-012-0322-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-012-0322-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T08:47:25Z","timestamp":1561711645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-012-0322-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,6]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["322"],"URL":"https:\/\/doi.org\/10.1007\/s00246-012-0322-8","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,6]]}}}